Deepa Wadhwa

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 338 citations

Urology, Oncology, Optimal Sequencing +8

Quality of life and mental health in caregivers of outpatients with advanced cancer

Deepa Wadhwa, Debika Burman, Nadia Swami et al. · Psycho-Oncology · 2011 · 211 citations

Quality Of Life, Family Medicine, Geriatric Psychiatry +17

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

Deepa Wadhwa, Nazanin Fallah‐Rad, Debjani Grenier et al. · Breast Cancer Research and Treatment · 2008 · 152 citations

Retrospective Study, Breast Oncology, Medicine +7

Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care

David Hausner, Colombe Tricou, Jean Mathews et al. · The Oncologist · 2020 · 75 citations · Full text

Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial

Matti Annala, Simon Fu, Jack V. W. Bacon et al. · Annals of Oncology · 2021 · 67 citations

Urology, Phase Ii Trial, Genitourinary Cancer +8